ASCENDIS PHARMA A/S: Financial statements 2023
CVR: 29918791
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ASCENDIS PHARMA A/S (CVR 29918791) has filed annual accounts for 2023. In 2023, the company reported revenue of EUR 266,718,000 and a net result of EUR -481,447,000 compared with EUR -583,194,000 the year before. That is an increase of 421.2% compared with the year before. The profit margin was -180.5%. Equity in the 2023 report amounted to EUR -145,697,000. The company had 851 employees in the financial year.
- Revenue
- EUR 266,718,000
- Gross Profit
- EUR 222,323,000
- Profit/Loss
- EUR -481,447,000
- Equity
- EUR -145,697,000
- Total Assets
- EUR 825,587,000
- Employees
- 851
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 266.7 mio. EUR | 222.3 mio. EUR | -481.4 mio. EUR | -145.7 mio. EUR | 851 |
| 2022 | 51.2 mio. EUR | 39 mio. EUR | -583.2 mio. EUR | 263.3 mio. EUR | 719 |
| 2021 | 7.8 mio. EUR | 4.3 mio. EUR | -383.6 mio. EUR | 883.6 mio. EUR | - |
| 2020 | 7 mio. EUR | - | -419 mio. EUR | 838.7 mio. EUR | - |
| 2019 | 13.4 mio. EUR | - | -218 mio. EUR | 597.1 mio. EUR | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 29, 2023, Rafaèle Tordjman has left the board of directors of ASCENDIS PHARMA A/S.
ASCENDIS PHARMA A/S has published its annual report for 2022. Revenue came to DKK 51,174,000, and the net result was DKK -583,194,000.
About ASCENDIS PHARMA A/S
ASCENDIS PHARMA A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ASCENDIS PHARMA ApS and CADENZA PARTNERS ApS. The management consists of Jan Møller Mikkelsen, Anni Lotte Kirstine Pedersen and Michael Wolff Jensen. The board consists of Albert Cha (chair), Jan Møller Mikkelsen, Jean-Jacques Bienaime and Lars Holtug. The company is owned by Cede & Co. The company has 688 employees (2026). In 2025, the company reported revenue of EUR 720,132,000 and a net result of EUR -228,034,000 compared with EUR -378,084,000 the year before. Equity in the 2025 report amounted to EUR -162,821,000.